Abstract
The Australian Group on Antimicrobial Resistance (AGAR) provide national reports on Methicillin resistant and methicillin sensitive Staphylococcus aureus (MRSA) antibiogram patterns for 14 antibiotics based on a decade of using the First 100 clinical isolates from inpatients and outpatients tested in participating laboratories. The First 100 isolates provided by 5 Queensland hospitals to AGAR represent inpatient isolates for every second year, 2005 to 2009, and outpatients for every second year, 2000 to 2008. Validity of the resistance patterns idenitfied by the samples is imperative for national surveillance.
Highlights
The Australian Group on Antimicrobial Resistance (AGAR) provide national reports on Methicillin resistant and methicillin sensitive Staphylococcus aureus (MRSA) antibiogram patterns for 14 antibiotics based on a decade of using the First 100 clinical isolates from inpatients and outpatients tested in participating laboratories
AGAR inpatient data for 2007 and 2009 demonstrated significantly higher resistance levels compared with the full dataset with exception of Clindamycin and Gentamicin for 2009
Resistance patterns identified from 15 iterations indicated random sampling does not improve the validity of in- or outpatient antibiograms
Summary
The Australian Group on Antimicrobial Resistance (AGAR) provide national reports on Methicillin resistant and methicillin sensitive Staphylococcus aureus (MRSA) antibiogram patterns for 14 antibiotics based on a decade of using the First 100 clinical isolates from inpatients and outpatients tested in participating laboratories. The First 100 isolates provided by 5 Queensland hospitals to AGAR represent inpatient isolates for every second year, 2005 to 2009, and outpatients for every second year, 2000 to 2008. Validity of the resistance patterns idenitfied by the samples is imperative for national surveillance
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have